Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)(4-morpholinyl)methanone
2. Tak-117
3. Ink1117
4. Mln1117
1. 1268454-23-4
2. Mln1117
3. Mln-1117
4. Ink1117
5. Ink-1117
6. Agn-pc-0db6fl
7. Tak-117
8. [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone
9. Methanone, [6-(2-amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinyl-
10. 43j9q56t3w
11. 5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine
12. (6-(2-amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinylmethanone
13. Methanone, (6-(2-amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinyl-
14. (6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)(4-morpholinyl)methanone
15. Serabelisibum
16. (6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)-morpholin-4-ylmethanone
17. [6-(2-amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinylmethanone
18. 5-(3-(morpholine-4-carbonyl)imidazo(1,2-a)pyridin-6-yl)-1,3-benzoxazol-2-amine
19. Refchem:182491
20. Tak 117
21. (6-(2-aminobenzo[d]oxazol-5-yl)imidazo[1,2-a]pyridin-3-yl)(morpholino)methanone
22. Serabelisib [inn]
23. Mfcd15146372
24. Mln 1117
25. [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholino-methanone
26. [6-(2-amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinyl-methanone
27. Unii-43j9q56t3w
28. C19h17n5o3
29. Serabelisib [who-dd]
30. Gtpl8969
31. Orb1304485
32. Chembl3935857
33. Schembl12928418
34. Schembl29382156
35. Bdbm119531
36. Ex-a1112
37. Ink 1117
38. Mln1117; Ink1117
39. Nsc795384
40. S8581
41. Akos030526373
42. Ccg-268203
43. Cs-5490
44. Db14935
45. Ebc-520105
46. Nsc-795384
47. 1428967-74-1
48. Ac-33667
49. As-73722
50. Hy-12285
51. Db-084944
52. Ink-1117,mln-1117,tak-117
53. Serabelisib(tak-117,ink1117,mln1117)
54. Serabelisib(tak-117,ink1117,mln1117)?
55. Us9682141, 54
56. Serabelisib (ink-1117,mln-1117,tak-117)
57. Us9682141, 529
58. Brd-k73877023-001-01-9
59. Q27078071
| Molecular Weight | 363.4 g/mol |
|---|---|
| Molecular Formula | C19H17N5O3 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 98.9 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 557 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
ABOUT THIS PAGE
85
PharmaCompass offers a list of Serabelisib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Serabelisib manufacturer or Serabelisib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Serabelisib manufacturer or Serabelisib supplier.
A Serabelisib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Serabelisib, including repackagers and relabelers. The FDA regulates Serabelisib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Serabelisib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Serabelisib supplier is an individual or a company that provides Serabelisib active pharmaceutical ingredient (API) or Serabelisib finished formulations upon request. The Serabelisib suppliers may include Serabelisib API manufacturers, exporters, distributors and traders.
Serabelisib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Serabelisib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Serabelisib GMP manufacturer or Serabelisib GMP API supplier for your needs.
A Serabelisib CoA (Certificate of Analysis) is a formal document that attests to Serabelisib's compliance with Serabelisib specifications and serves as a tool for batch-level quality control.
Serabelisib CoA mostly includes findings from lab analyses of a specific batch. For each Serabelisib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Serabelisib may be tested according to a variety of international standards, such as European Pharmacopoeia (Serabelisib EP), Serabelisib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Serabelisib USP).
